This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed at $85.54 in the latest trading session, marking a +1.05% move from the prior day.
Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zimmer Biomet (ZBH) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Zimmer (ZBH) delivered earnings and revenue surprises of 1.28% and 2.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Medtronic (MDT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Medtronic (MDT) closed at $87.34, marking a +0.6% move from the previous day.
Medtronic (MDT) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed at $84.50 in the latest trading session, marking a +0.74% move from the prior day.
Medtronic (MDT) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed at $83.88 in the latest trading session, marking a +0.74% move from the prior day.
Investors Heavily Search Medtronic PLC (MDT): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.
This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Medtronic (MDT) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Medtronic (MDT) closed at $82.76, marking a +1.41% move from the previous day.
Medtronic (MDT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed the most recent trading day at $81.89, moving +0.06% from the previous trading session.
Green Thumb Industries Inc. (GTBIF) Soars 30.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Medtronic (MDT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed at $85.05 in the latest trading session, marking a +0.65% move from the prior day.
Here is What to Know Beyond Why Medtronic PLC (MDT) is a Trending Stock
by Zacks Equity Research
Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Medtronic (MDT) Stock Moves -0.39%: What You Should Know
by Zacks Equity Research
In the latest trading session, Medtronic (MDT) closed at $82.27, marking a -0.39% move from the previous day.
Medtronic (MDT) Down 4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Medtronic (MDT) Gets FDA's 510(k) Nod for Pediatric ICM
by Zacks Equity Research
This latest approval broadens Medtronic's scope within its Cardiovascular Diagnostics and Services wing within broader Cardiovascular business.
Is Trending Stock Medtronic PLC (MDT) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Is Most-Watched Stock Medtronic PLC (MDT) Worth Betting on Now?
by Zacks Equity Research
Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Analyst Blog Highlights Visa, Broadcom, Medtronic, Walt Disney and BP
by Zacks Equity Research
Visa, Broadcom, Medtronic, Walt Disney and BP are part of The Zacks top Analyst Blog.
Top Analyst Reports for Visa, Broadcom & Medtronic
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Broadcom Inc. (AVGO) and Medtronic plc (MDT).
Medtronic (MDT) Obtains U.S. Distribution Rights for BioButton
by Zacks Equity Research
Medtronic's (MDT) new deal with BioIntelliSense will ensure accessibility to BioButton for continuous vital sign measurements of general care patients in the United States.
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Down
by Zacks Equity Research
Medtronic (MDT) posts better-than-expected results for the fiscal first quarter and maintains earnings and sales outlook for the full year.
Medtronic (MDT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Medtronic (MDT) delivered earnings and revenue surprises of 0.89% and 2.34%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Haemonetics (HAE) Hits 52-Week High: What's Aiding the Stock?
by Zacks Equity Research
Investors are optimistic about Haemonetics' (HAE) potential in its Plasma franchise.